Confirmed MERS patients were less than one percent of all tested persons in Saudi Arabia.
Twelve patients are currently under treatment at various hospitals in Saud Arabia.
This paper provides a review of the drivers for emergence, highlights some emerging zoonotic diseases, and offers examples of One Health approaches to disease investigation, prevention and control.
This guidance document offers an algorithm on the public health investigation and management of possible cases of MERS-CoV.
This guidance document offers a risk assessment of MERS-CoV to UK residents and guidance for travellers to the Middle East on reducing the risk of getting MERS-CoV.
This resource offers a reference on middle east respiratory syndrome’s pathogenesis, case definitions, and clinical manifestations.
The Coalition for Epidemic Preparedness Innovations (CEPI), a coalition of 200 organizations, plans to bring four to six vaccine candidates to the end of phase 2 trials by 2021.
A disease is not a pandemic until it spreads worldwide.
The vaccine may be useful to protect target animals as well as humans from MERS-CoV and RABV infections.
Researchers modified a rabies virus, so that it contains a protein from the Middle East Respiratory Syndrome (MERS) virus and rabies; creating a vaccine that protects mice against both rabies and MERS.